References
- Cross section Evaluation Working Group, "ENDF/B-VI Summary documentation (ENDF-201)", Brookhaven National Laboratory Report No. BNL.NCS-17541, 8th ed., National Nuclear Data Center, (December 2000).
- Gearheart DM, Drogin A, Sowards K, Meigooni AS, Ibbott GS. Dosimetric characteristics of a new 125I brachytherapy source. Med Phys. 2000; 27: 2278-2285.
- http://www.nea.fr/abs/html/ccc-0740.html
- Kouwenhoven E, Laarse R, Schaart DR. Variation in interpretation of the AAPM TG-43 geometry factor leads to unclearness in brachytherapy dosimetry. Med Phys 2001; 28: 1965-1966.
- Li Z, Palta JR, Fan JJ. Monte Carlo calculations and experimental measurements of dosimetry parameters of a new 103Pd source. Med Phys. 2000; 27: 1108-1112.
- Li Z. Monte Carlo calculation of dosimetry parameters of the Urcor Prostaseed 125I source. Med Phys. 2000; 29: 2278-2285.
- Meigooni AS, Bharucha Z, Yoe-Sein M, Sowards K. Dosimetric characteristic of the best double -wall 103Pd brachytherapy source. Med Phys. 2001; 28: 2568-2575.
- Melhus CS, Rivard MJ. COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs. Med Phys. 2008; 35: 3364-3371.
- Monte Carlo Team, MCNP-A General Monte Carlo N-Particle Transport Code - Version 5, Los Alamos National Laboratory http://mcnp-green.lanl.gov/index.html
- Murali V, Kurup PGG, Mahadev P, Mahalakshmi S. Dosimetric analysis and comparison of IMRT and HDR brachytherapy in treatment of localized prostate cancer. J Med Phys. 2010; 35: 113-119.
- Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No.43. American Association of Physicists in Medicine. Med Phys. 1995; 22: 209-234.
- Nath R, Yue N, Shahnazi K, Bongiorni PJ. Measurement of dose-rate constant for 103Pd seeds with air-kerma strength calibration based upon a primary national standard. Med Phys. 2000; 27: 655-658.
- Popescu CC, Wise J, Sowards K, Meigooni AS, Ibbott GS. Dosimetric characteristic of the Pharma Seed model BT-125-I source. Med Phys. 2000; 27: 2174-2181.
- Raisali Gh, Ghonchehnazi MG, Shokrani P, Sadeghi M. Monte Carlo and experimental characterization of the first AMIRS 103Pd brachytherapy. Appl Radiat Isot. 2008: 66: 1856-1860.
- Rivard MJ, Coursey BM, DeWerd LA, Hanson WF, Huq MS, Ibbott GS, Mitch MG, Nath R, Williamson JF. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys. 2004; 31: 633-674.
- Rivard MJ. Monte Carlo calculation of AAPM Task Group Report No.43 dosimetry parameters for the MED3631-A/M 125I source. Med Phys. 2001; 28: 629-637.
- Sadeghi M, Hosseini SH, Raisali Gh. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source. Appl Radiat Isot 2008; 66: 1431-1437.
- Sadeghi M, Raisali Gh, Hosseini SH, Shahvar A. Monte Carlo calculations and experimental measurements of dosimetric parameters of the IRA-103Pd brachytherapy source. Med Phys. 2008; 35: 1288-1294.
- Saidi P, Sadeghi M, Shirazi A, Tenreiro C. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source. Med Phys. 2010; 37: 2509-2515.
- Wallace RE, Fan JJ. Dosimetric characterization of a new design 103-palladium brachytherapy source. Med Phys. 1999; 26: 2465-2470.
- Williamson JF. Monte Carlo modeling of the transverse-axis dose distribution of the model 200 103Pd interstitial brachytherapy source. Med Phys. 2000; 27: 643-654.
- Zhang H, Martin D, Chiu-Tsao S, Meigooni A, Thomadsen B. A comprehensive dosimetric between 131Cs and 125I brachytherapy sources for COMS eye plaque implant. Brachytherapy 2010; 9: 362-372.